| Literature DB >> 23239825 |
Sascha Just1, Susann Illing, Michelle Trester-Zedlitz, Elaine K Lau, Sarah J Kotowski, Elke Miess, Anika Mann, Christian Doll, Jonathan C Trinidad, Alma L Burlingame, Mark von Zastrow, Stefan Schulz.
Abstract
Differences in the ability of opioid drugs to promote regulated endocytosis of μ-opioid receptors are related to their tendency to produce drug tolerance and dependence. Here we show that drug-specific differences in receptor internalization are determined by a conserved, 10-residue sequence in the receptor's carboxyl-terminal cytoplasmic tail. Diverse opioids induce receptor phosphorylation at serine (S)375, present in the middle of this sequence, but opioids differ markedly in their ability to drive higher-order phosphorylation on flanking residues [threonine (T)370, T376, and T379]. Multi-phosphorylation is required for the endocytosis-promoting activity of this sequence and occurs both sequentially and hierarchically, with S375 representing the initiating site. Higher-order phosphorylation involving T370, T376, and T379 specifically requires GRK2/3 isoforms, and the same sequence controls opioid receptor internalization in neurons. These results reveal a biochemical mechanism differentiating the endocytic activity of opioid drugs.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23239825 PMCID: PMC3583494 DOI: 10.1124/mol.112.082875
Source DB: PubMed Journal: Mol Pharmacol ISSN: 0026-895X Impact factor: 4.436